Veröffentlichungen Translationale Medizin

Vollständige Publikationslisten nach Jahren von 2009 bis 2015 können Sie in unseren Jahresberichten einsehen (für 2015 in den Annex Facts).


Stand August 2017

Borsari, C., Santarem, N., Torrado, J., Olías, A.I., Corral, M.J., Baptista, C., Gul, S., Wolf, M., Kuzikov, M., Ellinger, B., Witt, G., Gribbon, P., Reinshagen, J., Linciano, P., Tait, A., Costantino, L., Freitas-Junior, L.H., Moraes, C.B., Bruno dos Santos, P., Alcântara, L.M., Franco, C.H., Bertolacini, C.D., Fontana, V., Tejera Nevado, P., Clos, J., Alunda, J.M., Cordeiro-da-Silva, A., Ferrari, S., Costi, M.P., 2017. Methoxylated 2’-hydroxychalcones as antiparasitic hit compounds. European Journal of Medicinal Chemistry 126, 1129–1135.

Braig, F., Kriegs, M., Voigtlaender, M., Habel, B., Grob, T., Biskup, K., Blanchard, V., Sack, M., Thalhammer, A., Batalla, I.B., Braren, I., Laban, S., Danielczyk, A., Goletz, S., Jakubowicz, E., Märkl, B., Trepel, M., Knecht, R., Riecken, K., Fehse, B., Loges, S., Bokemeyer, C., Binder, M., 2017. Cetuximab resistance in head and neck cancer is mediated by EGFR-K521 polymorphism. Cancer Research 77, 1188–1199.

Dehne, N., Mora, J., Namgaladze, D., Weigert, A., Brüne, B., 2017. Cancer cell and macrophage cross-talk in the tumor microenvironment. Current Opinion in Pharmacology 35, 12–19.

Di Pisa, F., Landi, G., Dello Iacono, L., Pozzi, C., Borsari, C., Ferrari, S., Santucci, M., Santarem, N., Cordeiro-Da-Silva, A., Moraes, C.B., Alcantara, L.M., Fontana, V., Freitas-Junior, L.H., Gul, S., Kuzikov, M., Behrens, B., Pöhner, I., Wade, R.C., Costi, M.P., Mangani, S., 2017. Chroman-4-one derivatives targeting pteridine reductase 1 and showing anti-parasitic activity. Molecules 22.

Dimova, V., Oertel, B.G., Lötsch, J., 2017. Using a standardized clinical quantitative sensory testing battery to judge the clinical relevance of sensory differences between adjacent body areas. Clinical Journal of Pain 33, 37–43.

Fuhrmann, D.C., Brüne, B., 2017. Mitochondrial composition and function under the control of hypoxia. Redox Biology 12, 208–215.

Grösch, S., Niederberger, E., Geisslinger, G., 2017. Investigational drugs targeting the prostaglandin E2 signaling pathway for the treatment of inflammatory pain. Expert Opinion on Investigational Drugs 26, 51–61.

Hohmann, S.W., Angioni, C., Tunaru, S., Lee, S., Woolf, C.J., Offermanns, S., Geisslinger, G., Scholich, K., Sisignano, M., 2017. The G2A receptor (GPR132) contributes to oxaliplatin-induced mechanical pain hypersensitivity. Scientific Reports 7.

Janas, C., Mast, M.-P., Kirsamer, L., Angioni, C., Gao, F., Mäntele, W., Dressman, J., Wacker, M.G., 2017. The dispersion releaser technology is an effective method for testing drug release from nanosized drug carriers. European Journal of Pharmaceutics and Biopharmaceutics 115, 73–83.

Jeske, J., Windshügel, B., Thasler, W.E., Schwab, M., Burk, O., 2017. Human pregnane X receptor is activated by dibenzazepine carbamate-based inhibitors of constitutive androstane receptor. Archives of Toxicology 91, 2375–2390.

Jung, M., Mertens, C., Bauer, R., Rehwald, C., Brüne, B., 2017. Lipocalin-2 and iron trafficking in the tumor microenvironment. Pharmacological Research 120, 146–156.

Koch, A., Grammatikos, G., Trautmann, S., Schreiber, Y., Thomas, D., Bruns, F., Pfeilschifter, J., Badenhoop, K., Penna-Martinez, M., 2017. Vitamin D supplementation enhances C18(Dihydro)ceramide levels in type 2 diabetes patients. International Journal of Molecular Sciences 18.

Kringel, D., Sisignano, M., Zinn, S., Lötsch, J., 2017. Next-generation sequencing of the human TRPV1 gene and the regulating co-players LTB4R and LTB4R2 based on a custom AmpliSeqTM panel. PLoS ONE 12.

Niederberger, E., Resch, E., Parnham, M.J., Geisslinger, G., 2017. Drugging the pain epigenome. Nature Reviews Neurology 13, 434–447.

Parnham, M.J., 2017. Progress does not just come in giant leaps: adapting techniques for the study of inflammation to novel applications. Inflammation Research 66.

Pierre, S., Linke, B., Suo, J., Tarighi, N., Del Turco, D., Thomas, D., Ferreiros, N., Stegner, D., Frölich, S., Sisignano, M., Meyer Dos Santos, S., deBruin, N., Nüsing, R.M., Deller, T., Nieswandt, B., Geisslinger, G., Scholich, K., 2017. GPVI and Thromboxane Receptor on Platelets Promote Proinflammatory Macrophage Phenotypes during Cutaneous Inflammation. Journal of Investigative Dermatology 137, 686–695.

Rahlff, J., Peters, J., Moyano, M., Pless, O., Claussen, C., Peck, M.A., 2017. Short-term molecular and physiological responses to heat stress in neritic copepods Acartia tonsa and Eurytemora affinis. Comparative Biochemistry and Physiology -Part A : Molecular and Integrative Physiology 203, 348–358.

Schneider, C., Oellerich, T., Baldauf, H.-M., Schwarz, S.-M., Thomas, D., Flick, R., Bohnenberger, H., Kaderali, L., Stegmann, L., Cremer, A., Martin, M., Lohmeyer, J., Michaelis, M., Hornung, V., Schliemann, C., Berdel, W.E., Hartmann, W., Wardelmann, E., Comoglio, F., Hansmann, M.-L., Yakunin, A.F., Geisslinger, G., Ströbel, P., Ferreirós, N., Serve, H., Keppler, O.T., Cinatl, J., 2017. SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia. Nature Medicine 23, 250–255.

Stolz, A., Putyrski, M., Kutle, I., Huber, J., Wang, C., Major, V., Sidhu, S.S., Youle, R.J., Rogov, V.V., Dötsch, V., Ernst, A., Dikic, I., 2017. Fluorescence-based ATG8 sensors monitor localization and function of LC3/GABARAP proteins. EMBO Journal 36, 549–564.

Ueck, C., Volksdorf, T., Houdek, P., Vidal-Y-Sy, S., Sehner, S., Ellinger, B., Lobmann, R., Larena-Avellaneda, A., Reinshagen, K., Ridderbusch, I., Kohrmeyer, K., Moll, I., Daniels, R., Werner, P., Merfort, I., Brandner, J.M., 2017. Comparison of in-vitro and ex-vivo wound healing assays for the investigation of diabetic wound healing and demonstration of a beneficial effect of a triterpene extract. PLoS ONE 12.

Wobst, I., Ebert, L., Birod, K., Wegner, M.-S., Hoffmann, M., Thomas, D., Angioni, C., Parnham, M.J., Steinhilber, D., Tegeder, I., Geisslinger, G., Grösch, S., 2017. R-flurbiprofen traps prostaglandins within cells by inhibition of multidrug resistance-associated protein-4. International Journal of Molecular Sciences 18.

Zinn, S., Sisignano, M., Kern, K., Pierre, S., Tunaru, S., Jordan, H., Suo, J., Treutlein, E.-M., Angioni, C., Ferreiros, N., Leffler, A., Debruin, N., Offermanns, S., Geisslinger, G., Scholich, K., 2017. The leukotriene B4 receptors BLT1 and BLT2 form an antagonistic sensitizing system in peripheral sensory neurons. Journal of Biological Chemistry 292, 6123–6134.


A - C

Auffray, C., Balling, R., Barroso, I., Bencze, L., Benson, M., Bergeron, Bernal- Delgado E. et al.: Making sense of big data in health research: Towards an EU action plan. Genome Medicine (2016) No.8(1): 71 (

Aygören-Pürsün, E., Magerl, M., Graff, J., Martinez-Saguer, I., Kreuz, W., Longhurst, H., Nasr, I., Bas, M., Straßen, U., Fang, L., Cornpropst, M., Dobo, S., Collis, P., Sheridan, W.P., Maurer, M.: Prophylaxis of hereditary angioedema attacks: A randomized trial of oral plasma kallikrein inhibition with avoralstat. The Journal of Allergy Clinical Immunology (2016) pii: S0091-6749(16)30270-6 (

Barthelmes, J., Tafferner, N., Kurz, J., de Bruin, N., Parnham, M.J., Geisslinger, G., Schiffmann, S.: Induction of experimental autoimmune encephalomyelitis in mice and evaluation of the disease-dependent distribution of immune cells in various tissues. Journal of visualized experiments: JoVE. Online resource 2016 (2016) No. 111 (

Behrens, F., Koehm, M., Thaci, D., Gnann, H., Greger, G., Wittig, B.M., Burkhardt, H.: Anti-citrullinated protein antibodies are linked to erosive disease in an observational study of patients with psoriatic arthritis. Rheumatology 55 (2016) No. 10: 1791- 1795 (

Behrens, F., Koehm, M., Arndt, U., Wittig, B.M., Greger, G., Thaci, D., Scharbatke, E., Tony, H.-P., Burkhardt, H.: Does concomitant methotrexate with Progadalimumab influence treatment outcomes in patients with psoriatic arthritis? Data from a large observational study. The Journal of Rheumatology 43 (2016) No. 3: 632-639 (

Behrens, F., Thaci, D., Wollenhaupt, J., Krüger, K.: Psoriasisarthritis: Übersicht medikamentöser Therapieoptionen und Anwendungsbesonderheiten. Zeitschrift für Rheumatologie 75 (2016) No. 5, 471-488 (

Beyer, S., Xie, L., Schmidt, M., de Bruin, N., Ashtikar, M., Rüschenbaum, S., Lange, C.M., Vogel, V.; Mäntele, W., Parnham, M.J., Wacker, M.G.: Optimizing novel implant formulations for the prolonged release of biopharmaceuticals using in vitro and in vivo imaging techniques. Journal of controlled release 235 (2016), 352-364 (

Blöcher, R., Lamers, C., Wittmann, S.K., Merk, D., Hartmann, M., Weizel, L., Diehl, O., Brüggerhoff, A., Boss, M., Kaiser, A., Schader, T., Gobel, T., Grundmann, M., Angioni, C., Heering, J., Geisslinger, G., Wurglics, M., Kostenis, E., Brüne, B., Steinhilber, D., Schubert-Zsilavecz, M., Kahnt, A.S., Proschak, E.: N-Benzylbenzamides: A novel merged scaffold for orally available dual soluble epoxide hydrolase/peroxisome proliferator-activated receptor gamma modulators. Journal of medicinal chemistry 59 (2016) No. 1: 61-81 (

Bodewein, L., Schmelter, F., Di Fiore, S., Hollert, H., Fischer, R., Fenske, M.: Differences in toxicity of anionic and cationic PAMAM and PPI dendrimers in zebrafish embryos and cancer cell lines. Toxicology and Applied Pharmacology 305 (2016) 83-92 (

Borsari, C., Luciani, R., Pozzi, C., Poehner, I., Henrich, S., Trande, M., Cordeiro-da- Silva, A., Santarem, N., Baptista, C., Tait, A., Di Pisa, F., Dello Iacono, L., Landi, G., Gul, S., Wolf, M., Kuzikov, M., Ellinger, B., Reinshagen, J., Witt, G., Gribbon, P., Kohler, M., Keminer, O., Behrens, B., Costantino, L., Tejera Nevado, P., Bifeld, E., Eick, J., Clos, J., Torrado, J., Jiménez- Antón, M.D., Corral, M.J., Alunda, J.M., Pellati, F., Wade, R.C., Ferrari, S., Mangani, S., Costi, M.P.: Profiling of flavonol derivatives for the development of antitrypanosomatidic drugs. Journal of Medicinal Chemistry (2016) No. 59(16): 7598-7616 (

Boß, M., Newbatt, Y., Gupta, S., Collins, I., Brüne, B., Namgaladze, D.: AMPK-independent inhibition of human macrophage ER stress response by AICAR. Scientific Reports 6 (2016), Art. 32111, 10 (

Brändl, B., Schuldt, B.M., Böhnke, L., Keminer, O., Vaas, L.A.I., Fischer, R., Müller, F.J., Pless, O.: Utilizing regulatory networks for pluripotency assessment in stem cells. Current Stem Cell Reports (2016), No. 2(3): 228-235. Review. (

Brenke, J.K., Salmina, E.S., Ringelstetter, L., Dornauer, S., Kuzikov, M., Rothenaigner, I., Schorpp, K., Giehler, F., Gopalakrishnan, J., Kieser, A., Gul, S., Tetko, I.V., Hadian, K.: Identification of small-molecule frequent hitters of glutathione s-transferase- glutathione interaction. Journal of Biomolecular Screening 21 (2016) No.6: 596-607 (

Brenneis, M., Aghajaanpour, R., Knape, T., Sha, L.K., Neb, H., Meybohm, P., Zacharowski, K., Hauser, I.A., Buttner, S., Parnham, M.J., Brune, B., Von Knethen, A.: Pparg Expression in T Cells as a Prognostic Marker of Sepsis. Shock 45 (2016), No. 6: 591-597 (

Briken, S., Rosenkranz, S.C., Keminer, O., Patra, S., Ketels, G., Heesen, C., Hellweg, R., Pless, O., Schulz, K.H., Gold, S.M.: Effects of exercise on irisin, BDNF and IL-6 serum levels in patients with progressive multiple sclerosis. Journal of Neuroimmunology (2016) No. 299: 53-58 (

Brüne, B., Courtial, N., Dehne, N., Syed, S.N., Weigert, A.: Macrophage NOS2 in tumor leukocytes. Antioxidants & Redox Signaling. [Epub ahead of print] (

Bruin, N.M.W.J. de, Schmitz, K., Schiffmann, S., Tafferner, N., Schmidt, M., Jordan, H., Häußler, A., Tegeder, I., Geisslinger, G., Parnham, M.J.: Multiple rodent models and behavioral measures reveal unexpected responses to FTY720 and DMF in experimental autoimmune encephalomyelitis. Behavioural Brain Research 300 (2016) 160-174 (

Bruin de, N.M.W.J., van Loevezijn, A., Wicke, K.M., de Haan, M., Venhorst, J., Lange, J.H.M., de Groote, L., van der Neut, M.A.W., Prickaerts, J., Andriambeloson, E., Foley, A.G., van Drimmelen, M., van der Wetering, M., Kruse, C.G.: The selective 5-HT6 receptor antagonist SLV has putative cognitive- and social interaction enhancing properties in rodent models of cognitive impairment. Neurobiology of Learning and Memory (2016) No. 133: 100–117 ( )

Budu-Aggrey, A., Bowes, J. Loehr, S., Uebe, S., Zervou, M.I., Helliwell, P., Ryan, A.W., Kane, D., Korendowych, E., Giardina, E., Packham, J., McManus, R., Fitzgerald, O., McHugh, N., Behrens, F., Burkhardt, H., Huffmeier, U., Ho, P., Martin, J., Castaneda, S., Goulielmos, G., Reis, A.; Barton, A.: Replication of a distinct psoriatic arthritis risk variant at the IL23R locus. Annals of the rheumatic diseases 75 (2016) No. 7: 1417-1418 (

Budu-Aggrey, A., Bowes, J. Loehr, S., Uebe, S., Zervou, M.I., Helliwell, P., Ryan, A.W., Kane, D., Korendowych, E., Giardina, E., Packham, J., McManus, R., FitzGerald, O., McHugh, N., Behrens, F., Burkhardt, H., Huffmeier, U., Ho, P., Martin, J., Castaneda, S., Goulielmos, G., Reis, A., Barton, A.: Validation of a distinct psoriatic arthritis risk variant at IL23R. Rheumatology 55 (2016), Supplement 1, Abstract 219, i150-i151

Burkhardt, H., Weisenseel, P., Radtke, M.A., Krüger, K.: Hautmalignome und immunmodulierende Antirheumatikatherapie. Zeitschrift für Rheumatologie 75 (2016), No. 1: 32-40 (

Capelo, R., Lehmann, C., Ahmad, K., Snodgrass, R., Diehl, O., Ringleb, J., Flamand, N., Weigert, A., Stark, H., Steinhilber, D., Kahnt, A.S.: Cellular analysis of the histamine H4 receptor in human myeloid cells. Biochemical pharmacology 103 (2016) 74-84 (

Combe, B., Behrens, F., McHugh, N., Brock, F., Kerkmann, U., Kola, B., Gallo, G.: Comparison of etanercept monotherapy and combination therapy with methotrexate in psoriatic arthritis: Results from 2 clinical trials. The Journal of Rheumatology 43 (2016) No. 6: 1063-1067 (


D - F

de Araujo, L.S., Vaas, L.A., Ribeiro-Alves, M., Geffers, R., Mello, F.C., de Almeida, A.S., Moreira, A.D., Kritski, A.L., Lapa, E Silva JR, Moraes, M.O., Pessler, F., Saad, M.H.: Transcriptomic biomarkers for tuberculosis: Evaluation of DOCK9. EPHA4, and NPC2 mRNA expression in peripheral blood. Frontiers in Microbiology (2016) No. 7: 1586 (

Dillmann, C., Ringel, C., Ringleb, J., Mora, J., Olesch, C., Finl, A.F., Roberts, E., Brüne, B., Weigert, A.: S1PR4 signaling attenuates ILT7 internalization to limit IFN-a production by human plasmacytoid dendritic cells. The Journal of Immunology (2016) No. 196 (4): 1579-1590 (

Drebes, J., Künz, M., Windshügel, B., Kikhney, A.G., Müller, I.B., Eberle, R.J., Oberthür, D., Cang, H., Svergun, D.I., Perbandt, M., Betzel, C., Wrenger, C.: Structure of ThiM from vitamin B1 biosynthetic pathway of Staphylococcus aureus – insights into a novel pro-drug approach addressing MRSA infections. Scientific Reports (2016) No. 6: 22871 (

Ellinger, B., Gribbon P.: Risk mitigation in academic drug discovery. Expert Opinion on Drug Discovery (2016) No. 133(4): 333-336 (

Fenske, M., Gul, S.: Zebrafish early-life stages as neurological screening and detection tools. Drug Target Review, Volume 3, Autumn 2016, 41-43 (URL:

Frenz, T., Grabski, E., Buschjäger, D., Vaas, L.A., Burgdorf, N., Schmidt, R.E., Witte, T., Kalinke, U.: CD4(+) T cells in patients with chronic inflammatory rheumatic disorders show distinct levels of exhaustion. The Journal of Allergy Clinical Immunology (2016) No. 138(2): 586-589.e10 (


G - L

Graff, J., Scheuermann, E.H., Brandhorst, G., Oellerich, M., Gossmann, J.: Pharmacokinetic analysis of mycophenolate mofetil and enteric-coated mycophenolate sodium in calcineurin inhibitor-free renal transplant recipients. Ther Drug Monit. (2016) No. 38(3): 388-392 (

Grimm, M., Tischner, D., Troidl, K., Albarran Juarez, J., Sivaraj, K. K., Ferreiros Bouzas, N., Geisslinger, G., Binder, C. J., Wettschureck, N.: S1P2/G12/13 Signaling Negatively Regulates Macrophage Activation and Indirectly Shapes the Atheroprotective B1-Cell Population. Arteriosclerosis, Thrombosis, and Vascular Biology 36 (2016) No. 1: 37-48 (

Hanke, T., Merk, D., Steinhilber, D., Geisslinger, G., Schubert-Zsilavecz, M.: Small molecules with anti-inflammatory properties in clinical development. Pharmacology & therapeutics 157 (2016) 163-87 (

Hauser, A.S., Windshügel, B.: LEADS-PEP: A benchmark data set for assessment of peptide docking performance. Journal of Chemical Information and Modeling 2016 Jan 25; No. 56(1): 188- 200 (

Henke, N., Ferreiros, N., Geisslinger, G., Ding, M. G., Essler, S., Fuhrmann, D. C., Geis, T., Namgaladze, D., Dehne, N., Brune, B.: Loss of HIF-1alpha in macrophages attenuates AhR/ARNT-mediated tumorigenesis in a PAH-driven tumor model. Oncotarget 7 (2016) No. 18: 25915-29 (

Hunzelmann, N., Riemekasten, G., Becker, M.O., Moinzadeh, P., Kreuter, A., Melchers, I., Mueller-Ladner, U., Meier, F., Worm, M., Lee, H., Herrgott, I., Pfeiffer, C., Fierlbeck, G., Henes, J., Juche, A., Zeidler, G., Mensing, H., Günther, C., Sárdy, M., Burkhardt, H., Koehm, M., Kuhr, K., Krieg, T., Sunderkötter, C.: The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase- 1 antibodies. The British Journal of Dermatology 174 (2016) No. 6: 1384-1387 (

Josipovic, I., Fork, C., Preussner, J., Prior, K. K., Iloska, D., Vasconez, A. E., Labocha, S., Angioni, C., Thomas, D., Ferreiros, N., Looso, M., Pullamsetti, S. S., Geisslinger, G. Steinhilber, D., Brandes, R. P., Leisegang, M. S.: PAFAH1B1 and the lncRNA NONHSAT073641 maintain an angiogenic phenotype in human endothelial cells. Acta Physiologica 2018 (2016) No. 1: 13-27 (

Kemmerer, M., Wittig, I., Richter, F., Brüne, B., Namgaladze, D.: AMPK activates LXRa and ABCA1 expression in human macrophages. The International Journal of Biochemistry & Cell Biology (2016) No. 78: 1-9 (

King-Himmelreich, T.S., Schramm, S., Wolters, M.C., Schmetzer, J., Moser, C.V., Knothe, C., Resch, E., Peil, J., Geisslinger, G., Niederberger, E.: The impact of endurance exercise on global and AMPK gene-specific DNA methylation. Biochemical and Biophysical Research Communications 474 (2016) No. 2: 284-290 (

Klemmt, P.A., Resch, E., Smyrek, I., Engels, K., Stelzer, E.H., Starzinski-Powitz, A.: Alternative exon usage creates novel transcript variants of tumor suppressor SHREW-1 gene with differential tissue expression profile. Biology Open 15 (2016) No. 5(11), 1607-1619 (

Klingler, F.M., Wolf, M., Wittmann, S., Gribbon, P., Proschak, E.: Bacterial expression and HTS assessment of soluble epoxide hydrolase phosphatase. Journal of Biomolecular Screening (2016) No. 7: 689-94 (

Knothe, C., Shiratori, H., Resch, E., Ultsch, A., Geisslinger, G., Doehring, A., Lotsch, J.: Disagreement between two common biomarkers of global DNA methylation. Clinical Epigenetics 8 (2016) 60 (

Knothe, C., Oertel, B. G., Ultsch, A., Kettner, M., Schmidt, P. H., Wunder, C., Toennes, S. W., Geisslinger, G., Lotsch, J.: Pharmacoepigenetics of the role of DNA methylation in mu-opioid receptor expression in different human brain regions. Epigenomics 8 (2016) No. 12: 1583- 1599 (

Kringel, D., Ultsch, A., Zimmermann, M. ,Jansen, J.P., Ilias, W., Freynhagen, R., Griessinger, N., Kopf, A., Stein, C., Doehring, A., Resch, E., Lotsch, J.: Emergent biomarker derived from next-generation sequencing to identify pain patients requiring uncommonly high opioid doses. Pharmacogenomics Journal (2016) 1-8 (

Loers, G., Saini, V., Mishra, B., Gul, S., Chaudhury, S., Wallqvist, A., Kaur, G., Schachner, M.: Vinorelbine and epirubicin share common features with polysialic acid and modulate neuronal and glial functions. Journal of Neurochemistry (2016) No. 136(1): 48-62 (

Loevezijn van, A., Venhorst, J., Iwema Bakker, W.I., Lange, J.H.M., de Looff, W., Henzen, R., de Vries, J., van de Woestijne, R.P., den Hartog, A.P., Verhoog, S., van der Neut, M.A.W., de Bruin, N.M.W.J., Kruse, C.G.: Optimization of N’-(arylsulfonyl) pyrazoline-1-carboxamidines by exploiting a novel interaction site in the 5-HT6 antagonistic binding pocket. Bioorganic & Medicinal Chemistry Letters (2016), No. 26: 1605–1611 ( 10.1016/j.bmcl.2016.02.001)

Lötsch, J., Ultsch, A.: A computational functional genomics based self-limiting self-concentration mechanism of cell specialization as a biological role of jumping genes. Integrative Biology 8 (2016) No. 1: 91-103 (

Lötsch, J., Ultsch, A., Hummel, T.: How many and which odor identification items are needed to establish normal olfactory function? Chemical Senses 41 (2016) No. 4: 339-344 (

Lötsch, J., Ultsch, A.: A machine-learned computational functional genomics-based approach to drug classification. European Journal of Clinical Pharmacology 72 (2016), No. 12: 1449-1461 (

Lötsch, J., Ultsch, A.: Process Pharmacology: A Pharmacological Data Science Approach to Drug Development and Therapy. CPT. Pharmacometrics & Systems Pharmacology 5 (2016), No. 4: 192-200 (

Lötsch, J., Dimova, V., Ultsch, A., Lieb, I., Zimmermann, M., Geisslinger, G., Oertel, B.G.: A small yet comprehensive subset of human experimental pain models emerging from correlation analysis with a clinical quantitative sensory testing protocol in healthy subjects. European Journal of Pain: EJP 20 (2016) No. 5: 777-789 (

Lötsch, J., Hähner, A., Gossrau, G., Hummel, C., Walter, C., Ultsch, A., Hummel, T.: Smell of paIntersection of nociception and olfaction. Pain 157 (2016) Nr. 10: 2152-2157 ( pain.0000000000000599)


M - O

Maculins, T., Fiskin, E., Bhogaraju, S., Dikic, I.: Bacteria-host relationship: Ubiquitin ligases as weapons of invasion. Cell Research 26 (2016) No. 4: 499-510 (

Maculins, T., Carter, N., Dorval, T., Hudson, K., Nissink, J.W.M., Hay, R.T., Alwan, H.: A generic platform for cellular screening against ubiquitin ligases. Scientific Reports 6 (2016), Art. 18940, 10 (

Meirer, K., Glatzel, D., Kretschmer, S., Wittmann, S. K., Hartmann, M., Blocher, R., Angioni, C., Geisslinger, G., Steinhilber, D., Hofmann, B., Furst, R., Proschak, E.: Design, Synthesis and Cellular Characterization of a Dual Inhibitor of 5-Lipoxygenase and Soluble Epoxide Hydrolase. Molecules 22 (2016) No. 1 (

Moll, J., Meyer dos Santos, S., Hils, B., Dornuf, F., Rodrigues Meyer dos Santos, I., Singer, O.C., Ferreiros, N., Labocha, S., Blücher, A., Harder, S., Krozer, V.: Micro-optical prototyping of a surface acoustic wave-based point-of-care coagulation assay and first application in anticoagulated patients. International Journal of Clinical Pharmacology and Therapeutics 54 (2016) No. 3: 177-184 (

Mora, J., Schlemmer, A., Wittig, I., Richter, F., Putyrski, M., Frank, A.-C., Han, Y., Jung, M., Ernst, A., Weigert, A., Brüne, B.: Interleukin-38 is released from apoptotic cells to limit inflammatory macrophage responses. J Mol Cell Biol 8 (2016), 426–438. (

Möser, C.V., Meissner, M., Laarmann, K., Olbrich, K., King-Himmelreich, T.S., Wolters, M.C., Geisslinger, G., Niederberger, E.: The protein kinase IKKepsilon contributes to tumour growth and tumour pain in a melanoma model. Biochemical Pharmacology 103 (2016), 64-73 (

Muth-Köhne, E., Westphal-Settele, K., Brückner, J., Konradi, S., Schiller, V., Baumann, L., Schäfers, C., Teigeler, M., Fenske, M.: Corrigendum to „Linking the response of endocrine regulated genes to adverse effects on sex differentiation improves comprehension of aromatase inhibition in a Fish Sexual Development Test“. [Aquat. Toxicol. 176 (2016) 116-127] Aquatic Toxicology 177 (2016) 536 (

Muth-Köhne, E., Westphal-Settele, K., Brückner, J., Konradi, S., Schiller, V., Baumann, L., Schäfers, C., Teigeler, M., Fenske, M.: Linking the response of endocrine regulated genes to adverse effects on sex differentiation improves comprehension of aromatase inhibition in a Fish Sexual Development Test. Aquatic Toxicology 176 (2016) 116-127 (

Ören, B., Urosevic, J., Mertens, C., Mora, J., Guiu, M., Gomis, R.R., Weigert, A., Schmid, T., Grein, S., Brüne, B., Jung, M.: Tumour stroma-derived lipocalin-2 promotes breast cancer metastasis. Journal of Pathology 239 (2016) No. 3: 274-285 (


P - U

Parnham, M.J. (Ed.): Compendium of Inflammatory Diseases. Springer, Basel (2016). ISBN: 978-3- 0348-0620-6 (DOI 10.1007/978-3-7643-8550-7;

Parnham, M.J. (Ed.): Compendium of Inflammatory Diseases. Springer, Basel (2016). ISBN: 978-3- 0348-0620-6 (DOI 10.1007/978-3-7643-8550-7;

Pierre, S., Linke, B., Jing, S., Tarighi, N., Del Turco, D., Thomas, D., Ferreiros, N., Stegner, D., Frölich, S., Sisignano, M., Meyer Dos Santos, S., de Bruin, N., Nüsing, R.M., Deller, T., Nieswandt, B., Geisslinger, G., Scholich, K.: GPVI and thromboxane receptor on platelets promote proinflammatory macrophage phenotypes during cutaneous inflammation. Journal of Investigative Dermatology (in press) (

Roos, J., Grösch, S., Werz, O., Schröder, P., Ziegler, S., Fulda, S., Paulus, P., Urbschat, A., Kühn, B., Maucher, I., Fettel, J., Vorup-Jensen, T., Piesche, M., Matrone, C., Steinhilber, D., Parnham, M.J., Maier, T.J.: Regulation of tumorigenic Wnt signaling by cyclooxygenase-2, 5-lipoxygenase and their pharmacological inhibitors: a basis for novel drugs targeting cancer cells? Pharmacology and Therapeutics 157 (2016) 43-64 (

Samir, M., Vaas, L.A., Pessler, F.: MicroRNAs in the host response to viral infections of veterinary importance. Frontiers in Veterinary Science (2016) No. 3: 86 (

Scharbatke, E.C., Behrens, F., Schmalzing, M., Koehm, M., Greger, G., Gnann, H., Burkhardt, H., Tony, H.P.: Association of improvement in pain with therapeutic response as determined by individual improvement criteria in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 68 (2016) 68: 1607-1615 (

Schmid, T., Blees, J.S., Bajer, M.M., Wild, J., Pescatori, L., Cuzzucoli Crucitti, G., Scipione, L., Costi, R., Henrich, C.J., Brüne, B., Colburn, N.H., Di Santo, R.: Diaryl disulfides as novel stabilizers of tumor suppressor Pdcd4. PLOS ONE 11 (2013), No. 3: e0151643 (

Schneider, C., Oellerich, T., Baldauf, H. M., Schwarz, S. M., Thomas, D., Flick, R., Bohnenberger, H., Kaderali, L., Stegmann, L., Cremer, A., Martin, M., Lohmeyer, J., Michaelis, M., Hornung, V., Schliemann, C., Berdel, W. E., Hartmann, W., Wardelmann, E., Comoglio, F., Hansmann, M. L., Yakunin, A. F., Geisslinger, G., Strobel, P., Ferreiros, N., Serve, H., Keppler, O. T., Cinatl, J., Jr.: SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia. Nature Medicine 23 (2016) No. 2: 250- 55 (

Schröder, M., Kolodzik, A., Windshügel, B., Krepstakies, M., Priyadarshini, P., Hartjen, P., van Lunzen, J., Rarey, M., Hauber, J., Meier, C.: Linker-region modified derivatives of the deoxyhypusine synthase inhibitor CNI-1493 suppress HIV-1 replication. Archiv der Pharmazie (Weinheim) (2016) No. 349(2): 91-103. (

Shiratori, H., Feinweber, C., Knothe, C., Lötsch, J., Geisslinger, G., Parnham, M.J., Resch, E.: High-throughput analysis of global DNA methylation using methyl sensitive digestion. PLOS ONE. Online journal 11(10): e0163184 (2016)  (

Sisignano, M. , Angioni, C. , Park, C.- K., Meyer Dos Santos, S., Jordan, H., Kuzikov, M., Liu, D., Zinn, S., Hohman, S.W., Schreiber, Y., Zimmer, B., Schmidt, M., Lu, R., Suo, J., Zhang, D.-D., Schäfer, S.M.G., Hofmann, M., Yekkirala, A.S., de Bruin, N., Parnham, M.J., Woolf, C.J., Ji, R.-R., Scholich, K., Geisslinger, G.: Targeting CYP2J to reduce paclitaxelinduced peripheral neuropathic pain. Proceedings of the National Academy of Sciences (2016) No. 113: 12544–12549 (

Sisignano, M., Parnham, M.J., Geisslinger, G.: Drug repurposing for the development of novel analgesics. Trends in Pharmacological Sciences 37 (2016)172-83 (

Smolen, J.S., Breedveld, F.C., Burmester, G.R., Bykerk, V.,M Dougados, M., Emery, P., Kvien, T.K., Navarro-Compán, M.V., Oliver, S., Schoels, M., Scholte-Voshaar, M., Stamm, T., Stoffer, M., Takeuchi, T., Aletaha, D., Andreu, J.L., Aringer, M., Bergman, M., Betteridge, N., Bijlsma, H., Burkhardt, H., Cardiel, M., Combe, B., Durez, P., Fonseca, J.E., Gibofsky, A., Gomez-Reino, J.J., Graninger, W., Hannonen, P., Haraoui, B., Kouloumas, M., Landewe, R., Martin-Mola, E., Nash, P., Ostergaard, M., Östör, A., Richards, P., Sokka-Isler, T., Thorne, C., Tzioufas, A.G., van Vollenhoven, R., de Wit, M., van der Heijde, D.: Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 75 (2016) 3-15 (

Tafferner, N., Barthelmes, J., Eberle, M., Ulshöfer, T., Henke, M., deBruin, N., Mayer, C., Foerch, C., Geisslinger, G., Parnham, M.J., Schiffmann, S.: Alpha-methylacyl-CoA racemase deletion has mutually counteracting effects on T-cell responses, associated with unchanged course of EAE. European Journal of Immunology (2016) No. 46(3): 570-581 (

Thom, V., Schmid, S., Gelderblom, M., Hackbusch, R., Kolster, M., Schuster, S., Thomalla, G., Keminer, O., Pleß, O., Bernreuther, C., Glatzel, M., Wegscheider, K., Gerloff, C., Magnus, T., Tolosa, E.: IL-17 production by CSF lymphocytes as a biomarker for cerebral vasculitis. Neurology: Neuroimmunology & Neuroin lammation (2016) No. 3(2): e214 (

Ufer, F., Vargas, P., Engler, J.B., Tintelnot, J., Schattling, B., Winkler, H., Bauer, S., Kursawe, N., Willing, A., Keminer, O., Ohana, O., Salinas-Riester, G., Pless, O., Kuhl, D., Friese, M.A.: Arc/Arg3.1 governs inflammatory dendritic cell migration from the skin and thereby controls T cell activation. Science Immunology (2016): No. 1(3): pp. eaaf8665 (


V - Z

Vaas, L.A.I., Witt, G., Windshügel, B., Bosin, A., Serra, G., Bruengger, A., Winterhalter, M., Gribbon, P., Levy-Petelinkar, C.J., Kohler, M.: Electronic laboratory notebooks in a public-private-partnership. PeerJ Computer Science (2016) No. 2: e83 (

Wacker, M.G., Proykova, A., Santos, G.M.L.: Dealing with nanosafety around the globe – regulation vs. innovation. International Journal of Pharmaceutics 509 (2016) No.1-2: 95-106 (

Walter, C., Knothe, C., Lötsch, J.: Abuse-deterrent opioid formulations: pharmacokinetic and pharmacodynamic considerations. Clinical pharmacokinetics 55 (2016) No. 7, 751-767 (

Walter, C., Oertel, B.G., Felden, L., Kell, C.A., Nöth, U., Vermehren, J., Kaiser, J., Deichmann, R., Lötsch, J.: Brain mapping-based Model of D(9)-tetrahydrocannabinol effects on connectivity in the pain matrix. Neuropsychopharmacology. 2016 May;41(6):1659-69 (

Wegner, M. S., Schiffmann, S., Parnham, M. J., Geisslinger, G., Grosch, S.: The enigma of ceramide synthase regulation in mammalian cells. Progress in Lipid Research 63 (2016) 93-119 (

Winkel, A.F., Engel, C.K., Margerie, D., Kannt, A., Szillat, H., Glombik, H., Kallus, C., Ruf, S., Güssregen, S., Riedel, J., Herling, A.W., von Knethen, A., Weigert, A., Brüne, B., Schmoll, D.: Characterization of RA839, a noncovalent small molecule binder to Keap1 and selective activator of Nrf2 signaling. Journal of Biological Chemistry 290 (2015) No. 47: 28446-28455 (

Wobst, I., Ebert, L., Birod, K., Wegner, M. S., Hoffmann, M., Thomas, D., Angioni, C., Parnham, M. J., Steinhilber, D., Tegeder, I., Geisslinger, G., Grosch, S.: R-flurbiprofen traps prostaglandins within cells by inhibition of multidrug resistance-associated protein-4. International Journal of Molecular Sciences 18 (2016) No. 1 (

Zschiebsch, K., Fischer, C., Pickert, G., Haussler, A., Radeke, H., Grosch, S .; Ferreiros, N., Geisslinger, G., Werner, E. R., Tegeder, I.: Tetrahydrobiopterin attenuates DSSevoked colitis in mice by rebalancing redox and lipid signalling. Journal of Crohn‘s and Colitis 10 (2016) No. 8: 965-78 (